The Factor V Leiden mutation has a very low prevalence (0.4%) among African-American pregnant women, suggesting they are not at increased risk for carrying this mutation.
No takes yet. Share an insight, caveat, or question.
May not support routine Factor V Leiden screening in African-American pregnancies; leaves open ethnic-specific thrombophilia prevalence and testing strategies.
Rose et al. (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: